1. Zagury D., I. Gagne, B. Reveil, J-F. Zagury, P. Sarin, R.C. Gallo. Repairing the T cell defect in AIDS. The Lancet (1985) 2, 556-557.

2. Franchini G., E. Collalti, S.K. Arya, E.M. Fenyo, G. Biberfeld, J-F. Zagury, P.J. Kanki, F. Wong-Staal, R.C. Gallo. Genetic analysis of a new subgroup of human and simian T-lymphotropic retroviruses : HTLV-IV, LAV-2, SBL-6669, and STLV-IIIagm. AIDS Res Human Retroviruses (1987) 3, 11-17.

3. Arya S.K., B. Beaver, L. Jagodzinski, B. Ensoli, P.J. Kanki, J.Albert, E.M. Fenyo, G. Biberfeld, J-F. Zagury, F. Laure, M. Essex, E. Norrby, F. Wong-Staal, R.C. Gallo. New human and simian HIV-related posess functional transactivator (tat) gene. Nature (1987) 328, 548-550.

4. Leonard R., D. Zagury, I. Desportes, J. Bernard, J-F Zagury, R.C. Gallo. Cytopathic effect of HIV in T4 cells is linked to the last stage of virus infection. Proc Natl Acad Sci USA (1988) 85, 3570-3574.

5. Zagury J-F., G. Franchini, M. Reitz, E. Collalti, B. Starcich, L. Hall, K. Fargnoli, L. Jagodzinski, F. Laure, S.K. Arya, S. Josephs, D. Zagury, F. Wong-Staal, R.C. Gallo. Genetic variability between isolates of human immunodeficiency virus (HIV) type 2 is comparable to the variability among HIV type 1. Proc Natl Acad Sci USA (1988) 85, 5941-5945.

6. Agius G., V. Vaillant, G. Dindinaud, M. Bazillou, J-F. Zagury, V. Kolenitchenko, M. Castets. HTLV-1, HIV-1 and HIV-2 seroprevalences in Guadeloupe, French West Indies. Eur J Epidemiol (1989) 5, 532.

7. Mars M., J-F. Zagury, I. Fossati, G. Beaud. Variable proteolytic cleavage of gag precursor expressed after infection of several cell lines with an HIV-2 gag-pol recombinant vaccinia virus. AIDS Res Hum Retroviruses (1990) 6, 271-273.

8. Zagury J-F., S.F. Josephs, G. Agius, I. Nicol, A. Willer, V.S. Kalyanaraman, D. Zagury, F. Wong-Staal, R.C. Gallo. In vitro characterization of a biologically active molecular clone of HIV-2 (NIHZ) containing a nef deletion and expressing a full-length transmembrane protein. AIDS Res Human Retroviruses (1990) 6,1079-1085.

9. Agius G., V. Kolenitchenko, R. Snart, J-F. Zagury, K. Laaroubi, D. Zagury. Variable stringency hybridization of polymerase chain reaction amplified HIV-1 DNA fragments. J Virol Methods. (1990) 30, 141-150.

10. Callebaut I., J-F. Zagury, D. Portetelle, A. Burny, D. Zagury. Sequence homologies between HIV envelope and alpha1 antitrypsin suggest a new way to understand the cleavage mechanism and infectivity. Archives Internationales de Physiologie, de Biochimie et de Biophysique. (1991) 99, B50.

11. Zagury D., Bernard J., Halbreich A., Bizzini B., Carelli C., Achour A., Defer M.C., Bertho J.M., Zagury J-F., Salaun J.J., Lurhuma Z., Aboud-Pirak E., Lowell G., Lebon P., Burny A., Picard O. One-Year follow-up of vaccine therapy in HIV-infected immune deficient individuals: A new strategy. J Acquir Immune Defic Syndr (1992) 5, 676-681.

12. Carelli C., Halbreich A., Bernard J., Bizzini B., Achour A., Zagury J-F., Lebon P., Pollioti B., Folghera S., Laaroubi K., Aboud-Pirak E., Lowell G., Burny A., Picard O., Zagury D. Immunogenicity of combined anti-HIV and anti-suppressive vaccine preparations. Biomed Pharmacother (1992) 46, 149-153.

13. Zagury J-F., Cantalloube H., Bernard J., Bizzini B., Mornon J.P., Zagury D. A striking identity between HIV-1 envelope glycoprotein gp120 and its CD4 receptor. Lancet (1992) 340, 483-484

14. Zagury J-F., Cantalloube H., Bernard J., Lachgar A., Fall L., Achour A., Mbika J.P., Cosme M.H., Pellion F., Issing W., Carelli C., Bizzini B., Thoreau E., Callebaut I., Burny A., Mornon J.P., Zagury D. Critical sites: a semantic approach to protein sequences. Application to the HIV-1 envelope molecule. Biomed Pharmacother (1992) 46, 343-351.

15. Picard O., Bernard J., Lachgar A., Fall L., Carlotti M., Achour A., Carelli C., Salaun J.J., Mbika J.P., Lurhuma Z., Desgranges C., Boyer V., Burny A., Zagury J-F., Bizzini B., Zagury D. Removal of gp160 induced bio-hazards for a safe AIDS vaccine candidate. Biomed Pharmacother (1992) 46, 353-357.

16. Zagury J-F., Bernard J., Achour A., Astgen A., Lachgar A., Fall L., Carelli C., Issing W., Mbika J.P., Cantalloube H., Picard O., Gourbil A., Guignon JM, Cozette J, Carlotti M., Callebaut I., Mornon J.P., Burny A., Feldman M., Bizzini B., Zagury D. HIV-1 induced immune suppression may result from autoimmune disorders including anti-SLWDQ autoantibodies. Biomed Pharmacother (1993) 47, 93-99.

17. Kolenitchenko V., Agius G., Zagury J-F., Laaroubi K., Achour A., Castets M., Zagury D. Polymerase chain reaction amplified HTLV-1, HIV-1, and HIV-2 DNA fragments in subjects with mixed retroviral infections. J Med Microbiol (1993) 38, 328-336.

18. Issing W.J., Dreps A., Heppt W.J., Wustrow T.P., Riederer A., Zagury J-F. Erb-2/Her-2 gene amplification and overexpression in parotid gland tumors. Eur Arch Otorhinolaryngol (1993) 250, 150-153.

19. Zagury J-F., Cantalloube H., Bernard J., Lachgar A., Fall L., Callebaut I., Burny A., Mornon J.P., Zagury D. Computer studies on HIV-1 proteins: identification of critical sites. J Acquir Immune Defic Syndr (1993) 6, 680.

20. Zagury J-F., Bernard J., Achour A., Astgen A., Lachgar A., Fall L., Carelli C., Issing W., Mbika J.P., Picard O., Carlotti M., Callebaut I., Mornon J.P., Burny A., Feldman M., Bizzini B., Zagury D. Identification of CD4 and MHC functional peptide sites and their homology with HIV-1 gp120 oligopeptides: role in AIDS pathogenesis. Proc Natl Acad Sci USA (1993) 90, 7573-7577.

21. Zagury J-F., Cantalloube H., Achour A., Cho Y.Y., Fall L., Lachgar A., Chams V., Astgen A., Biou D., Issing W., Picard O., Callebaut I., Mornon J.P., Burny A., Bernard J., Bizzini B., Zagury D. Striking similarities between HIV-1 env protein and the apoptosis mediating cell surface antigen Fas. Role in AIDS pathogenesis. Biomed Pharmacoth (1993) 47, 331-335.

22. Bex F., Becker N., Collette Y., Deschamps M., Gonzales S., Hermans P., Lambrecht B., Van De Perre P., Vanhulle C., Zagury J-F., Zagury D., Clumeck N., Burny A. Vaccination against AIDS: facts, problems and hopes for success, in AIDS-SIDA, A comparison between Europe and Africa, Editions Roche, (1993) p 21-32.

23. Cantalloube H., Nahum C., Achour A., Lehner T., Callebaut I., Burny A., Bizzini B., Mornon J-P., Zagury D., Zagury J-F. Automat: a novel software for the systematic search of proteins (or DNA) similarities with a notable application to autoimmune diseases. Bioinformatics (1994) 10, 153-161.

24. Achour A., Lemhammedi S., Picard O., Mbika JP., Zagury J-F., Moukrim Z., Willer A., Beix F., Burny A., Zagury D. Cytotoxic T lymphocytes specific for HIV-1 gp160 antigen and synthetic P18 peptide in a HLA-A11 immunized individual. AIDS Res Human Retroviruses (1994) 10, 19-25.

25. Achour A., Moukrim Z., Zagury J-F., Picard O., BURny A. and Zagury D. Detection of CTL activity in PBMCs taken from HIV-ENV immunized individuals after in vitro viral infection. Biomed & Pharmacother (1994) 48, 7-10.

26. Zagury J-F., Lachgar A., Achour A., Chams-Harvey V., Cho Y.Y., Le Coq H., Bizzini B., Feldman M., Burny A. and Zagury D. Pathogenic disorders involved in immunosuppression and T cell depletion characterizing AIDS. Biomed & Pharmacother (1994) 48, 11-16.

27. Cantalloube H., Nahum C. E., Zagury J-F. Screening of protein sequences databanks by Automat for search of host sequences integration and/or autoimmune disorders induction by retroviruses. Biomed & Pharmacother (1994) 48, 17-26.

28. Chams V., Biou D., Cho Y.Y., Mbika J-P., Lecoq H., Fouchard M., Heshmatti F., Bizzini B., Zagury J-F. Effect of purified IgGs from HIV-1-infected and non infected individuals on immune activation. Biomed Pharmacoth (1994) 48, 267-272.

29. Gringeri A., Sanagostino E., Manucci P.M., Tradati F., Cultaro D., Buzzi A., Criscuolo M., David A., Guillemot L., Barre-Sinoussi F., Lachgar A., Chams V., Lecoq H., Fouchard M., Achour A., Fall L., Defer C., Picard O., Hermans P., Burny A., Feldman M., Chany C., Zagury J-F., Bizzini B., Zagury D. A randomized, placebo-controlled, blind anti-AIDS clinical trial: safety and immunogenicity of a specific anti-IFN_ immunization. J Acquir Immune Defic Syndr (1994) 7, 978-988.

30. Zagury J-F., Chams V., Lachgar A., Achour A., Zagury D., Cohen P., Bizzini B., Burny A., Feldman M. Are CD4 and Fas peptide identities of gp120 relevant to the molecular basis of AIDS pathogenesis? Cell Death & Differ 1995;2:23-31.

31. Cantalloube H., Labesse G., Chomilier J., Nahum C., Cho Y.Y., Chams V., Achour A., Lachgar A., Mbika J.P., Issing W., Mornon J-P., Bizzini B., Zagury D., Zagury J-F. Automat and Blast: comparison of two sequence similarity search programs. Bioinformatics 1995;11:261-272.

32. Achour A., Bizzini B., Burny A., Zagury D., Zagury J-F. A CD4 pentapeptide as an in vitro target for specific CTLs in HIV-1 infected individuals. Immunol & Infect Diseases 1995;5:270-276.

33. Lachgar A., Bernard J., Bizzini B., Astgen A., Le Coq H., Fouchard M., Chams V., Feldman M., Richardson M., Rappaport J., Burny A. & Zagury J-F. Repair of the in vitro HIV-1-induced immunosuppression and blockade of the generation of functional suppressive CD8 cells by anti-alpha interferon and anti-Tat antibodies. Biomed & Pharmacother. 1996;50:13-18.

34. Zagury J-F., Lachgar A., Bernard J., Bizzini B., Astgen A., Le Coq H., Fouchard M., Chams V., Feldman M., Richardson M., Rappaport J., Burny A., Zagury D. & Gallo R.C. A critical role of Tat and IFN_ in the HIV-1-induced immunosuppression leading to AIDS. AIDS Sciences 1996;3:97-103.

35. Gringeri A., Santagostino E., Cusini M., Muça-Perja M., Marinoni A., Mannucci P.M., Burny A., Criscuolo M., Lu W., Andrieux J.M. M'Bika J.P., Lachgar A., Fall L.S., Chams V., Feldman M., Hermans P., Zagury J.F., Bizzini B. & Zagury D. Absence of clinical, Virological and immunological signs of progression in HIV-1-infected patients receiving active anti-alpha interferon immunization: a 30 month follow-up report. J Acquir Immune Defic Syndr 1996;13:55-67.

36. Hendel H, Cho Y-Y, Gauthier N, Rappaport J, Schachter F, Zagury J-F. Contribution of cohort studies in understanding HIV pathogenesis: introduction of the GRIV cohort and preliminary results. Biomed Pharmacoth 1996;50:480-87.

37. Rappaport J, Cho Y-Y, Hendel H, Schwartz EJ, Schächter F, Zagury J-F. The 32 bp CCR-5 gene deletion confers resistance to fast progression among HIV-1 infected heterozygous individuals. The Lancet 1997;349:922-23.

38. Cho Y-Y, Astgen A, Hendel H, Issing I, Perrot Y, Schächter F, Rappaport J, Zagury J-F. Homeostatsis of chemokines, interferons production and lymphocyte subsets: implications for AIDS pathogenesis. Biomed Pharmacoth 1997;51:221-29.

39. Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury J-F, Bizzini B, Gringeri A, Santagostino E, Rappaport J, Feldman M, O'Brian SJ, Burny A & Gallo RC. C-C chemokines, pivotal in protection against HIV type 1 infection. Proc Natl Acad Sci USA 1998;95:3857-3861.

40. Zagury D, Lachgar A, Chams V, Fall LS, Bernard J, Zagury J-F, Bizzini B, Gringeri A, Santagostino E, Rappaport J, Feldman M, O'BriEn SJ, Burny A & Gallo RC. Interferon and Tat involvement in the immunosuppression of uninfected T cells and C-C chemokine decline in AIDS. Proc Natl Acad Sci USA 1998;95:3851-3856.

41. Zagury J-F, Sill A, Blattner W, Lachgar A, Le Buanec H, Richardson M, Rappaport J, Hendel H, Bizzini B, Gringeri A, Carcagno M, Criscuolo M, Burny A, Gallo RC & Zagury D. Antibodies to the HIV-1 Tat protein correlated with nonprogression to AIDS: A rationale for the use of Tat Toxoid as an HIV-1 vaccine. J Hum Virol 1998;1:282-292.

42. Gringeri A, Santagostino E, MuCa-Perja M, Mannucci PM, Zagury J-F, Bizzini B, Lachgar A, Carcagno M, Rappaport J, Criscuolo M, Blattner W, Burny A, Gallo RC & Zagury D. Safety and immunogenicity of HIV-1 Tat Toxoid in immunocompromised HIV-1-infected patients. J Hum Virol 1998;1:293-298.

43. Hendel H, Henon N, Lebuanec H, Lachgar A, Poncelet H, Caillat-Zucman S, Winkler C, Smith MW, Kenefic L, O'Brien SJ, Lu W, Andrieu JM, Zagury D, Schächter F, Rappaport J, Zagury J-F. Distinctive effects of CCR5, CCR2 and SDF1 genetic polymorphisms on AIDS progression. J Acquir Immune Defic Syndr 1998;19:381-386.

44. Le Buanec H, Lachgar A, Bizzini B, Zagury J-F, Rappaport J, Santagostino E, MuCa-Perja M & Gringeri A. A prophylactic and therapeutic AIDS vaccine containing as a component the innocuous Tat Toxoid. Biomed Pharmacother 1998;52:431-435.

45. Lachgar A, Jaureguiberry G, Le Buanec H, Bizzini B, Zagury J-F, Rappaport J & Zagury D. Binding of HIV-1 to RBCs involves the Duffi antigen receptors for chemokines (DARC). Biomed Pharmacother 1998;52:436-439.

46. Gringeri A, Musicco M, Hermans P, Bentwich Z, Cusini M, Bergamasco A, Santagostino E, Burny A, Bizzini B, Zagury D and the EURIS Study group. Active anti-interferon alpha immunization: a european-israeli randomized, double blind, placebo-controlled clinical trial in 242 HIV-1-infected patients (EURIS Study). J Acquir Immune Defic Syndr 1999;20:358-370.

47. Gringeri A, Santagostino E, Muca-Perja M, Le Buanec H, Bizzini B, Lachgar A, Zagury J-F, Rappaport J, Burny A, Gallo RC & Zagury D. Tat-Toxoid, a safe and immunogenic component for a preventive vaccine in seronegative subjects. J Acquir Immune Defic Syndr 1999;20:371-375.

48. Hendel H, Caillat-Zucman S, Le Buanec H, Carrington M, O'Brien S, Andrieu JM, Schachter F, Zagury D, Rappaport J, Winkler C, Nelson G & Zagury J-F. New class I and II HLA alleles strongly associated with opposite patterns of progression to AIDS. J Immunol 1999;162:6942-6946.

49 - Zagury D., Lecoq H., Gervi I., Le Buanec H., Zagury J-F, Bizzini B., Burny A., Hermans P., Muça-Perja M., Santagostino E. & Gringeri A.: Anti-IFN_ immunization raises the IFN_-neutralizing capacity of serum - an adjuvant to antiretroviral tritherapy. Biomed. & Pharmacother. 1999;53:90-92.

50 - Le Buanec H., Lachgar A., D'Anna R., Zagury J-F, Bizzini B., Bernard J., Ittelé D., Hallez S., Giannouli C., Burny A. & Zagury D.: Induction of cellular immunosuppression by the human papillomavirus type 16E7 oncogenic protein. Biomed. & Pharmacother. 1999;53:323-328.

51 - Le Buanec H., D'Anna R., Lachgar A., Zagury J-F, Bernard J., Ittelé D., D'Alessio P., Hallez S., Giannouli C., Burny A., Bizzini B., Gallo R.C. & Zagury D.: HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes. Biomed. & Pharmacother. 1999;53:424-431.

52 - Richardson MW, Sverstiuk A, Hendel H, Cheung TW, Zagury J-F, Rappaport J. Analysis of telomere length and thymic output in fast and slow/non-progressors with HIV infection. Biomed Pharmacoth 2000;54:21-31

53 - Ilunga AG, Kaba A, Achour A, Zagury J-F, Chany C. Expression of sarcolectin in sera from HIV-1 infected patients during progression of the disease. AIDS 2000;14:2206-7

54 - Capini CJ, Richardson, MW, Sverstiuk AE, Mirchandani J, Regulier EG, Khalili K, Zagury J-F, and Rappaport J. Auto-antibodies to TNF_ in HIV infection : prospects for anti-cytokine vaccine therapy. Biomed Pharmacoth 2001;55: 1-9

55 - Hendel H, Winkler C, Nelson G, Haumont P, O'Brien S, Khalili K, Zagury D, Rappaport J, Zagury J-F. Validation of genetic case-control studies in AIDS and application to the CX3CR1 polymorphism. J Acquir Immune Defic Syndr 2001;26:507-11.

56 - D'Anna R, Le Buanec H, Bizzini B, Burny A, Giannouli C, Zagury J-F, Gallo RC, Zagury D, D'Alessio P. Human papillomavirus-16-E7 oncoprotein enhances the expression of adhesion molecules in cervical endothelial cells but not in human umbilical vein endothelial cells. J Hum Virol 2001 4:85-95

57 - Dubois-Laforgue D, Hendel H, Caillat-Zucman S, Zagury J-F, Winkler C, Boitard C, Timsit J. A common stromal cell-derived factor-1 chemokine gene variant is associated with the early onset of type 1 diabetes. Diabetes 2001 50:1211-3

58 - Ioannidis JP, Rosenberg PS, Goedert JJ, Ashton LJ, Benfield TL, Buchbinder SP, Coutinho RA, Eugen-Olsen J, Gallart T, Katzenstein TL, Kostrikis LG, Kuipers H, Louie LG, Mallal SA, Margolick JB, Martinez OP, Meyer L, Michael NL, Operskalski E, Pantaleo G, Rizzardi GP, Schuitemaker H, Sheppard HW, Stewart GJ, Theodorou ID, Ullum H, Vicenzi E, Vlahov D, Wilkinson D, Workman C, Zagury J-F, O'Brien TR. Effects of CCR5-Delta32, CCR2-64I, and SDF-1 3'A Alleles on HIV-1 Disease Progression: An International Meta-Analysis of Individual-Patient Data. Ann Intern Med. 2001;135:782-795.

59 - D'Anna R, Le Buanec H, Alessandri G, Caruso A, Burny A, Gallo R, Zagury J-F, Zagury D, D'Alessio P. Selective activation of cervical microvascular endothelial cells by human Papillomavirus 16-E7 oncoprotein. J Natl Cancer Instit 2001;93:1843-51.

60 - Stevanovitch A, Taillé A, Garcin G, Spadoni JL, Frackowiak S, Coiffait PE, Béraud-Colomb E. Direct evidence of ancient human DNA from human bones up to twelve thousand years old by probe hybridization. Antropologie 2001;N°XXXIX/2-3:233-239.

61 - Mogentale-Profizi N, Chollet L, Stevanovitch A, Dubut V, Poggi C, Pradie MP, Spadoni JL, Gilles A. Beraud-Colomb E. Mitochondrial DNA sequence diversity in two groups of Italian Veneto speakers from Veneto. Ann Hum Genet 2001;65:153-166.

62 - Silvera P, Richardson MW, Greenhouse J, Yalley-Ogunro J, Shaw N, Mirchandani J, Khalili K, Zagury J-F, Lewis MG, Rappaport J. Outcome of simian-human immunodeficiency virus strain 89.6p challenge following vaccination of rhesus macaques with human immunodeficiency virus Tat protein. J Virol. 2002;76:3800-9.

63 - Kaba A, Ilunga AJ, Achour A, Zagury J-F, Chany C. The interferon antagonist sarcolectin in the progress of HIV-1 infection and in AIDS. J Interferon Cytokine Res. 2002;22:305-10.

64 - Richardson MW, Mirchandani J, Silvera P, Regulier EG, Capini C, Bojczuk PM, Hu J, Gracely EJ, Boyer JD, Khalili K, Zagury J-F, Lewis MG, Rappaport J. Immunogenicity of HIV-1 IIIB and SHIV 89.6P Tat and Tat toxoids in rhesus macaques: induction of humoral and cellular immune responses. DNA Cell Biol. 2002;21:637-51.

65 - Spadoni JL, Stevanovitch A, Béraud-Colomb E. Analysis of mitochondrial DNA of some cattle from the archaeological site of Lattara. British Archéological Report. 2002;S1017:59-62.

66 - Richardson MW, Mirchandani J, Duong J, Grimaldo S, Kocieda V, Hendel H, Khalili K, Zagury J-F, Rappaport J. Antibodies to Tat and Vpr in the GRIV cohort: differential association with maintenance of long-term non-progression status in HIV-1 infection. Biomed Pharmacother. 2003;57:4-14.

67 - Huber C, Pons H, Hendel H, Jacquemin L, Tamim S, Zagury J-F. Genomic studies in AIDS : problems and answers. Development of a statistical model integrating both longitudinal cohort studies and transversal observations of extreme cases. Biomed Pharmacother 2003; 57:25-33.

68 - Flores-Villanueva P, Hendel H, Caillat-Zucman S, Rappaport J, Burgos-Tiburcio A, Bertin-Maghit S, Ruiz-Morales JA, Teran ME, Rodriguez-Tafur J, Zagury J-F. Associations of MHC ancestral haplotypes with resistance/susceptibility to AIDS disease development. J Immunol 2003;170:1925-9

69 - Vasilescu A, Heath SC, Ivanova R, Hendel H, Do H, Mazoyer A, Khadivpour E, Goutalier FX, Khalili K, Rappaport J, Lathrop GM, Matsuda F and Zagury J-F. Genomic analysis of Th1-Th2 cytokine genes in an AIDS cohort: identification of IL4 and IL10 haplotypes and their association to the disease progression. Genes Immunity 2003;4:441-49.

70 - Richardson MW, Sverstiuk AE, Gracely EJ, Hendel H, Khalili K, Zagury J-F, Rappaport J.
T-cell receptor excision circles (TREC) and maintenance of long-term non-progression status in HIV-1 infection. AIDS 2003;17:915-7.

71 - Belliard G, Romieu A, Zagury J-F, Dali H, Chaloin O, Le Grand R, Loret E, Briand JP, Roques B, Desgranges C, Muller S. Specificity and effect on apoptosis of Tat antibodies from vaccinated and SHIV-infected rhesus macaques and HIV-infected individuals. Vaccine 2003;21:3186-99.

72 - Kefi R, Mafart B, Spadoni JL, Stevanovitch A, Eliane Béraud-Colomb E. Application de la technique de PCR en temps réel à l'étude de l'ADN ancien. C. R. Palevol 2003;2:125-132.

73 - Regulier EG, Reiss K, Khalili K, Amini S, Rappaport J, Zagury J-F, Katsikis PD. T-cell and neuronal apoptosis in HIV infection : implications for therapeutic intervention. Int Rev Immunol 2004;23: 25-59.

74 - Capini C, Bertin-Maghit S, Bessis N, Haumont P, Bernier E, Muel E, Laborie M, Autin L, Paturance S, Chomilier J, Boissier MC, Briand JP, Muller S, Cavaillon JM, Therwath A, Zagury J-F. Active immunization against murine TNFa peptides in mice : generation of endogenous antibodies cross-reacting with the native cytokine and in vivo protection. Vaccine 2004 ;22:3144-3153

75 - Stevanovitch A, Gilles A, Bouzaid E, Kefi R, Paris F, Gayraud RP, Spadoni JL, El- Chenawi F, Béraud-Colomb E. Mitochondrial DNA Sequence Diversity in a Sedentary Population from Egypt. Ann Hum Genet 2004;68: 23-39.

76 - Winkler CA, Hendel H, Carrington M, Smith MW, Nelson GW, O'brien SJ, Phair J, Vlahov D, Jacobson LP, Rappaport J, Vasilescu A, Bertin-Maghit S, An P, Lu W, Andrieu JM, Schachter F, Therwath A, Zagury J-F. Dominant Effects of CCR2-CCR5 Haplotypes in HIV-1 Disease Progression. J Acquir Immune Defic Syndr 2004;37:1534-38

77 - Vasilescu A, Heath SC, Diop G, Do H, Hirtzig T, Hendel H, Bertin-Maghit S, Rappaport J, Therwath A, Lathrop GM, Matsuda F, Zagury J-F. Genomic analysis of Fas and FasL genes and absence of correlation with disease progression in AIDS. Immunogenetics 2004;56:56-60

78 - Abbas A, Vasilescu A, Do H, Hendel H, Maachi M, Goutalier FX, Rappaport J, Matsuda F, Therwath A, Aucouturier P, Zagury J-F. Analysis of IgG and IgG4 in HIV-1 seropositive subjects and correlation with biological and genetic markers. Biomed Pharmacother 2005;59:38-46

79- Do H, Vasilescu A, Diop G, Hirtzig T, Heath SC, Therwath A, Coulonges C, Rappaport J, Lathrop M, Matsuda F, Zagury J-F. Exhaustive genotyping of the CEM15/APOBEC3G gene and absence of association with AIDS progression in a Caucasian cohort. J Infect Dis 2005;191:159-63.

80 - Cantalloube H, Chomilier J, Chiusa S, Lonquety M, Spadoni JL, Zagury J-F. Filtering redundancies for sequence similarity search programs. J Biomol Struct Dyn 2005;22:487-92

81 - Bertin-Maghit S, Capini C, Bessis N, Chomilier J, Muller S, Abbas A, Spadoni JL, Autin L, Rappaport J, Therwath A, Boissier MC, Zagury J-F. Improvement of collagen-induced arthritis by immunization against murine IL1b peptides designed by molecular modelling. Vaccine 2005;23:4228-35

82 - Alland C, Moreews F, Boens D, Carpentier M, Chiusa S, Lonquety M, Renault N, Wong Y, Cantalloube H, Chomilier J, Hochez J, Pothier J, Villoutreix BO, Zagury J-F, Tufféry P. RPBS: a web resource for structural bioinformatics. Nucleic Acids Res 2005;33:W44-W49

83 - Régulier EG, Panemangalore R, Richardson MW, DeFranco JJ, Kocieda V, Silvera P, Khalili K, Zagury J-F, Lewis MG, Rappaport J. Persistent anti-Gag, -Nef and -Rev IgMs levels as markers of the impaired functions of CD4+ T helpers lymphocytes during SIVmac251 infection of cynomolgus macaques. J Acquir Immune Defic Syndr 2005, in press

84 - Diop G, Spadoni JL, Do H, Hirtzig T, Coulonges C, Labib T, Issing W, Rappaport J, Therwath A, Lathrop M, Matsuda F, Zagury JF. Genomic approach of AIDS pathogenesis: exhaustive genotyping of the TNFR1 gene in a French AIDS cohort. Biomed Pharmacother 2005;59:474-80.

85 - Do H, Vasilescu A, Diop G, Hirtzig T, Coulonges C, Labib T, Heath SC, Spadoni JL, Therwath A, Lathrop M, Matsuda F, Zagury JF.
Associations of the IL2Ralpha, IL4Ralpha, IL10Ralpha, and IFNgR1 cytokine receptor genes with AIDS progression in a French AIDS cohort. Immunogenetics. 2006;58:89-98.

86 - Diop G, Hirtzig T, Do H, Coulonges C, Vasilescu A, Labib T, Spadoni JL, Therwath A, Lathrop M, Matsuda F, Zagury JF.Exhaustive genotyping of the interferon alpha receptor 1 (IFNAR1) gene and association of an IFNAR1 protein variant with AIDS progression or susceptibility to HIV-1 infection in a French AIDS cohort. Biomed Pharmacother. 2006;60:569-77.

87 - Coulonges C, Delaneau O, Girard M, Do H, Adkins R, Spadoni JL, Zagury JF. Computation of haplotypes on SNPs subsets: advantage of the "global method". BMC Genet. 2006;7:50

88 - Do H, Vasilescu A, Carpentier W, Meyer L, Diop G, Hirtzig T, Coulonges C, Labib T, Spadoni JL, Therwath A, Lathrop M, Matsuda F, Zagury JF.
Exhaustive genotyping of the interleukin-1 family genes and associations with AIDS progression in a French cohort. J Infect Dis. 2006;194:1492-504.

89 - Vasilescu A, Terashima Y, Enomoto M, Heath S, Poonpiriya V, Gatanaga H, Do H, Diop G, Hirtzig T, Auewarakul P, Lauhakirti D, Sura T, Charneau P, Marullo S, Therwath A, Oka S, Kanegasaki S, Lathrop M, Matsushima K, Zagury JF, Matsuda F. A haplotype of the human CXCR1 gene protective against rapid disease progression in HIV-1+ patients. Proc Natl Acad Sci U S A. 2007;104:3354-9.

90 - Delaneau O, Coulonges C, Boelle PY, Nelson G, Spadoni JL, Zagury JF. ISHAPE: new rapid and accurate software for haplotyping. BMC Bioinformatics. 2007;8:205.

91 - Limou S, Coulonges C, Foglio M, Heath S, Diop G, Leclerc S, Hirtzig T, Spadoni JL, Therwath A, Lambeau G, Gut I, Zagury JF. Exploration of associations between phospholipase A2 gene family polymorphisms and AIDS progression using the SNPlex method. Biomed Pharmacother. 2008; 62:31-40.

92 - Delavallée L, Assier E, Denys A, Falgarone G, Zagury JF, Muller S, Bessis N, Boissier MC. Vaccination with cytokines in autoimmune diseases.
Ann Med. 2008;40:343-51.

93 - Limou S, Le Clerc S, Coulonges C, Carpentier W, Dina C, Delaneau O, Labib T, Taing L, Sladek R, Deveau C, Ratsimandresy R, Montes M, Spadoni JL, Lelièvre JD, Lévy Y, Therwath A, Schächter F, Matsuda F, Gut I, Froguel P, Delfraissy JF, Hercberg S, Zagury JF; ANRS Genomic Group. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J Infect Dis. 2009 Feb 1;199(3):419-26.

94 - Abbadessa G, Accolla R, Aiuti F, Albini A, Aldovini A, Alfano M, Antonelli G, Bartholomew C, Bentwich Z, Bertazzoni U, Berzofsky JA, Biberfeld P, Boeri E, Buonaguro L, Buonaguro FM, Bukrinsky M, Burny A, Caruso A, Cassol S, Chandra P, Ceccherini-Nelli L, Chieco-Bianchi L, Clerici M, Colombini-Hatch S, de Giuli Morghen C, de Maria A, de Rossi A, Dierich M, Della-Favera R, Dolei A, Douek D, Erfle V, Felber B, Fiorentini S, Franchini G, Gershoni JM, Gotch F, Green P, Greene WC, Hall W, Haseltine W, Jacobson S, Kallings LO, Kalyanaraman VS, Katinger H, Khalili K, Klein G, Klein E, Klotman M, Klotman P, Kotler M, Kurth R, Lafeuillade A, La Placa M, Lewis J, Lillo F, Lisziewicz J, Lomonico A, Lopalco L, Lori F, Lusso P, Macchi B, Malim M, Margolis L, Markham PD, McClure M, Miller N, Mingari MC, Moretta L, Noonan D, O'Brien S, Okamoto T, Pal R, Palese P, Panet A, Pantaleo G, Pavlakis G, Pistello M, Plotkin S, Poli G, Pomerantz R, Radaelli A, Robertguroff M, Roederer M, Sarngadharan MG, Schols D, Secchiero P, Shearer G, Siccardi A, Stevenson M, Svoboda J, Tartaglia J, Torelli G, Tornesello ML, Tschachler E, Vaccarezza M, Vallbracht A, van Lunzen J, Varnier O, Vicenzi E, von Melchner H, Witz I, Zagury D, Zagury JF, Zauli G, Zipeto D. Unsung hero Robert C. Gallo. Science. 2009 Jan 9;323(5911):206-7.

95 - Ratsimandresy RA, Rappaport J, Zagury JF. Anti-cytokine therapeutics: history and update. Curr Pharm Des. 2009;15(17):1998-2025. Review. .

96 - Le Clerc S, Limou S, Coulonges C, Carpentier W, Dina C, Taing L, Delaneau O, Labib T, Sladek R; ANRS Genomic Group, Deveau C, Guillemain H, Ratsimandresy R, Montes M, Spadoni JL, Therwath A, Schächter F, Matsuda F, Gut I, Lelièvre JD, Lévy Y, Froguel P, Delfraissy JF, Hercberg S, Zagury JF. Genomewide association study of a rapid progression cohort identifies new susceptibility alleles for AIDS (ANRS Genomewide Association Study 03). J Infect Dis. 2009 Oct 15;200(8):1194-201.

97 - Giganti D, Guillemain H, Spadoni JL, Nilges M, Zagury JF, Montes M. Comparative evaluation of 3D virtual ligand screening methods: impact of the molecular alignment on enrichment. J Chem Inf Model. 2010 Jun 28;50(6):992-1004.

98 - Limou S, Coulonges C, Herbeck JT, van Manen D, An P, Le Clerc S, Delaneau O, Diop G, Taing L, Montes M, van't Wout AB, Gottlieb GS, Therwath A, Rouzioux C, Delfraissy JF, Lelièvre JD, Lévy Y, Hercberg S, Dina C, Phair J, Donfield S, Goedert JJ, Buchbinder S, Estaquier J, Schächter F, Gut I, Froguel P, Mullins JI, Schuitemaker H, Winkler C, Zagury JF. Multiple-cohort genetic association study reveals CXCR6 as a new chemokine receptor involved in long-term nonprogression to AIDS. J Infect Dis. 2010 Sep 15;202(6):908-15.

99 - Le Clerc S, Coulonges C, Delaneau O, Van Manen D, Herbeck JT, Limou S, An P, Martinson JJ, Spadoni JL, Therwath A, Veldink JH, van den Berg LH, Taing L, Labib T, Mellak S, Montes M, Delfraissy JF, Schächter F, Winkler C, Froguel P, Mullins JI, Schuitemaker H, Zagury JF. Screening low-frequency SNPS from genome-wide association study reveals a new risk allele for progression to AIDS. J Acquir Immune Defic Syndr. 2011 Mar;56(3):279-84.

100 - Bol SM, Moerland PD, Limou S, van Remmerden Y, Coulonges C, van Manen D, Herbeck JT, Fellay J, Sieberer M, Sietzema JG, van 't Slot R, Martinson J, Zagury JF, Schuitemaker H, van 't Wout AB. Genome-wide association study identifies single nucleotide polymorphism in DYRK1A associated with replication of HIV-1 in monocyte-derived macrophages. PLoS One. 2011 Feb 25;6(2):e17190.

101 - Troyer JL, Nelson GW, Lautenberger JA, Chinn L, McIntosh C, Johnson RC, Sezgin E, Kessing B, Malasky M, Hendrickson SL, Li G, Pontius J, Tang M, An P, Winkler CA, Limou S, Le Clerc S, Delaneau O, Zagury JF, Schuitemaker H, van Manen D, Bream JH, Gomperts ED, Buchbinder S, Goedert JJ, Kirk GD, O'Brien SJ. Genome-wide association study implicates PARD3B-based AIDS restriction. J Infect Dis. 2011 May 15;203(10):1491-502.

102 - Nikolova M, Carriere M, Jenabian MA, Limou S, Younas M, Kök A, Huë S, Seddiki N, Hulin A, Delaneau O, Schuitemaker H, Herbeck JT, Mullins JI, Muhtarova M, Bensussan A, Zagury JF, Lelievre JD, Lévy Y. CD39/adenosine pathway is involved in AIDS progression. PLoS Pathog. 2011 Jul;7(7):e1002110. doi: 10.1371/journal.ppat.1002110. .

103 - van Manen D, Delaneau O, Kootstra NA, Boeser-Nunnink BD, Limou S, Bol SM, Burger JA, Zwinderman AH, Moerland PD, van 't Slot R, Zagury JF, van 't Wout AB, Schuitemaker H. Genome-wide association scan in HIV-1-infected individuals identifying variants influencing disease course. PLoS One. 2011;6(7):e22208.

104 - Ratsimandresy RA, Duvallet E, Assier E, Semerano L, Delavallée L, Bessis N, Zagury JF, Boissier MC. Active immunization against IL-23p19 improves experimental arthritis. Vaccine. 2011 Nov 21;29(50):9329-36. Epub 2011 Oct 18.

105 - Delaneau O, Marchini J, Zagury JF. A linear complexity phasing method for thousands of genomes. Nat Methods. 2011 Dec 4;9(2):179-81. doi: 10.1038/nmeth.1785.

106 - Delaneau O, Zagury JF. Haplotype inference. Methods Mol Biol. 2012;888:177-96.

107 - Limou S, Melica G, Coulonges C, Lelièvre JD, Do H, McGinn S, Gut IG, Lévy Y, Zagury JF. Identification of IL7RA risk alleles for rapid progression during HIV-1 infection: a comprehensive study in the GRIV cohort. Curr HIV Res. 2012 Mar;10(2):143-50.

108 - Limou S, Delaneau O, van Manen D, An P, Sezgin E, Le Clerc S, Coulonges C, Troyer JL, Veldink JH, van den Berg LH, Spadoni JL, Taing L, Labib T, Montes M, Delfraissy JF, Schachter F, O'Brien SJ, Buchbinder S, van Natta ML, Jabs DA, Froguel P, Schuitemaker H, Winkler CA, Zagury JF. Multicohort genomewide association study reveals a new signal of protection against HIV-1 acquisition. J Infect Dis. 2012 Apr 1;205(7):1155-62.

109 - Delaneau O, Zagury JF, Marchini J. Improved whole-chromosome phasing for disease and population genetic studies. Nat Methods. 2013 Jan;10(1):5-6.

110 - Ben Nasr N, Guillemain H, Lagarde N, Zagury JF, Montes M. Multiple structures for virtual ligand screening: defining binding site properties-based criteria to optimize the selection of the query. J Chem Inf Model. 2013 Feb 25;53(2):293-311.

111 - Le Clerc S, Taing L, Ezzedine K, Latreille J, Delaneau O, Labib T, Coulonges C, Bernard A, Melak S, Carpentier W, Malvy D, Jdid R, Galan P, Hercberg S, Morizot F, Guinot C, Tschachler E, Zagury JF. A genome-wide association study in Caucasian women points out a putative role of the STXBP5L gene in facial photoaging. J Invest Dermatol. 2013 Apr;133(4):929-35.

[Accueil]-[Enseignements]-[Recherche]-[Formation continue]